This systematic review highlights curcumin’s effectiveness in reducing inflammation in oral diseases, suggesting its potential as an adjunctive therapy.
Curcumin, which is a polyphenol from the rhizomes of Curcuma longa, has been found to possess anti-inflammatory, antioxidant, and antimicrobial activities. This systematic review examines the effectiveness of curcumin in treating oral inflammation, e.g., periodontal diseases, gingivitis, oral lichen planus (OLP), and radiation-induced oral mucositis (ROM). The studies in this review assess different curcumin formulations, including gels, hydrogels, nano-curcumin, and mouthwashes, as adjunctive agents in oral inflammatory diseases. The studies indicate that curcumin significantly decreases clinical markers of inflammation, improves healing, and reduces patient discomfort, warranting its use as an adjunctive therapeutic agent.
No takes yet. Share an insight, caveat, or question.
Shunmugavelu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: